A Responder Analysis To Demonstrate Dupilumab Treatment Effect Across Objective and Patient-Reported Subjective Endpoints For Patients with Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

A Responder Analysis To Demonstrate Dupilumab Treatment Effect Across Objective and Patient-Reported Subjective Endpoints For Patients with Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Meeting Abstract

publication date

February 1, 2021

webpage

Web of Science

published in

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY Journal

start page

AB132

end page

AB132

volume

147

issue

2